Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: A double-blind, randomised, placebo-controlled study

Journal of Headache and Pain

Volumn 3, Issue 2, 2002, Pages 93-99

  Schnider, Peter ^a   Moraru, Ecaterina ^a   Vigl, Marion ^a   Wöber, Christian ^a   Földy, Daniela ^a   Maly, Joachim ^a   Bittner, Christian ^a   Wessely, Peter ^a   Auff, Eduard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Botulinum toxin type A; Cervical headache; Physical therapy

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; FEEDBACK SYSTEM; FEMALE; HEADACHE; HEAT TREATMENT; HUMAN; INJECTION PAIN; JOINT FUNCTION; MALE; MASSAGE; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; MUSCLE WEAKNESS; NECK MUSCLE; OUTPATIENT DEPARTMENT; PAIN ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 0036750379     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101940200024     Document Type: Article

References (18)

1. Jankovic J, Brin MF (1999) Therapeutic uses of botulinum toxin. N Engl J Med 324:1186-1194
2. Wheeler AH, Goolkasian P, Gretz SS, Fanciullo GJ (1998) A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 23:1662-1667
3. Cheshire WP, Abashian SW, Mann JD (1994) Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59:65-69
4. Freund BJ, Schwartz M (2000) Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache 40:231-236
5. Porta M (2000) A comparative trial of botulinum toxin type A and methyl-prednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85:101-105
6. Silberstein O, Matthew N, Saper J, Jenkins S (2000) Botulinum toxin type A as a migraine preventive treatment: for the BOTOX Migraine Clinical Research Group. Headache 40:445-450
7. Smuts JA, Baker MK, Smuts HM, Stassen JMR, Rossouw E, Barnard PWA (1999) Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 6[Suppl 4]:99-102
8. Hobson DE, Gladish DF (1997) Botulinum toxin injection for cervicogenic headache. Headache 37: 253-255
9. Relja M (1997) Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 4:S71-S73
10. Relja M (1998) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 8[Suppl 7]:1-96
11. Pearce JM (1995) Cervicogenic headache: a personal view. Cephalalgia 15:463-469
12. Pöllmann W, Keidel M, Pfaffenrath V (1997) Headache and the cervical spine: a critical review. Cephalalgia 17:801-816
13. Pfaffenrath V, Kaube H (1990) Diagnostics of cervicogenic headache. Funct Neurol 5:159-164
14. Nilsson N (1995) The prevalence of cervicogenic headache in a random population sample of 20-59-year olds. Spine 20:1884-1888
15. Sjaastad O, Fredriksen TA, Pfaffenrath V (1990) Cervicogenic headache: diagnostic criteria. Headache 30:725-726
16. Göbel H, Edmeads JG (2000) Disorders of the skull and cervical spine. In: Olesen J, Tfelt Hansen P, Welch KMA (eds) The headaches, 2nd edn. Lippincott Williams Wilkins, Philadelphia, pp 891-899
17. Aoki KR (2001) Pharmacology and immunology of botulinum toxin serotypes. J Neurol 248[Suppl 1]:I/3-I/10
18. Bellometi S, Galzigna L (1998) Serum levels of prostaglandin and leukotriene after thermal mud pack therapy. J Investig Med 46(4):140-145